Risk of cardiovascular disease: the effects of diabetes and anti-diabetic drugs - a nested case-control study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cardiology

• Publication date

  2015-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2014.11.096PMID 25465309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited

  2014cited by this paper
• Liraglutide and Insulin are Associated with a Decreased Risk of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients

  2014cited by this paper
• At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.

  2014cited by this paper
• Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

  2013cited by this paper
• Pharmacology, physiology, and mechanisms of incretin hormone action.

  2013cited by this paper
• Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

  2013cited by this paper
• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Exenatide Reduces Final Infarct Size in Patients With ST-Segment–Elevation Myocardial Infarction and Short-Duration of Ischemia

  2012cited by this paper
• The effect of glucagon-like peptide 1 on cardiovascular risk

  2012cited by this paper
• Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

  2011cited by this paper
• Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials

  2011cited by this paper
• Is Hyperglycemia a Cardiovascular Risk Factor?

  2011cited by this paper
• The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus.

  2010cited by this paper
• Intensive glycemic control and cardiovascular disease: an update

  2010cited by this paper
• Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

  2010cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes.

  2009cited by this paper
• Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women

  2007cited by this paper
• Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

  2007cited by this paper
• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

  2006cited by this paper
• Diabetic microvascular complications--can the presence of one predict the development of another?

  2006cited by this paper
• The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Hyperglycemia as a cardiovascular risk factor.

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

  2001cited by this paper
• Improved endothelial function with metformin in type 2 diabetes mellitus.

  2001cited by this paper
• Use and validation of public data files for identification of the diabetic population in a Danish county.

  2001cited by this paper
• The Danish National Hospital Register. A valuable source of data for modern health sciences.

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Epidemiology of coronary heart disease: the Framingham study.

  1984cited by this paper
• Oral Hypoglycaemic Agents

  1984cited by this paper
• Oral hypoglycaemic agents

  1973cited by this paper
• Pharmacology

  1941cited by this paper

• The Impact of Glucagon-Like Peptide-1 Receptor Agonist on the Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review

  2023cites this paper
• The Impact of Cardiac Comorbidity Sequence at Baseline and Mortality Risk in Type 2 Diabetes Mellitus: A Retrospective Population-Based Cohort Study

  2022cites this paper
• Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review

  2021cites this paper
• Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs): A systematic review and meta‐analysis of observational cohort studies

  2020cites this paper
• Glucagon-like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review

  2020cites this paper
• Design and analysis of nested case–control studies for recurrent events subject to a terminal event

  2019cites this paper
• Diabetes and Stroke: The Role of Glucose Regulation

  2019cites this paper
• PREVALENCE AND FACTORS ASSOCIATED WITH SELF-REPORTED DIABETES MELLITUS IN GAUTENG PROVINCE IN SOUTH AFRICA

  2018cites this paper
• Different mechanisms involved in liraglutide and glucagon‐like peptide‐1 vasodilatation in rat mesenteric small arteries

  2018cites this paper
• Curcumin-mediated effects on anti-diabetic drug-induced cardiotoxicity

  2018cites this paper
• Multi‐ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF‐ACTION trial and the ASIAN‐HF registry

  2018cites this paper
• Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.

  2018cites this paper
• Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used

  2017cites this paper
• Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics.

  2017cites this paper
• Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.

  2017cites this paper
• Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.

  2017cites this paper
• Association of glucagon‐like peptide‐1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system

  2017cites this paper
• Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

  2016cites this paper
• Pin1 in cardiovascular dysfunction: A potential double-edge role.

  2016cites this paper
• Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic

  2016cites this paper
• Life satisfaction in patients with and without spinal cord ischemia after advanced endovascular therapy for extensive aortic disease at mid-term follow-up.

  2016cites this paper
• Characteristics of midlife women with coronary microvascular dysfunction, compared with age-matched women with obstructive coronary disease

  2016cites this paper
• Role of endoplasmic reticulum stress in drug‐induced toxicity

  2016cites this paper
• Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists

  2016cites this paper
• Ultrasound Diagnosis of Hepatic Steatosis as a Surrogate for Atherosclerosis

  2016cites this paper
• Oral sensory nerve damage: Causes and consequences

  2016cites this paper
• White-coat hypertension and masked hypertension: an update

  2015cites this paper
• Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)

  2015cites this paper
• Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database.

  2015influential citation
• Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)

  2015cites this paper
• DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety.

  2015cites this paper
• Abacavir/Dolutegravir/Lamivudine Single-Tablet Regimen: A Review of Its Use in HIV-1 Infection

  2015cites this paper
• Pharmacological and Phytochemical Screening of Aegle marmelos (L.) and Cinnamomum tamala (Buch.-ham.) Leaves for Therapeutic Efficacy

  2014cites this paper
• NR3C1 polymorphisms in Brazilians of Caucasian, African, and Asian ancestry: glucocorticoid sensitivity and genotype association.

  2014cites this paper
• Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome

  2014cites this paper
• Lipidomics in longevity and healthy aging

  2013cites this paper
• Qualitative descriptive study of Mexican Americans health-seeking experience during myocardial infarction

  2013cites this paper
• Dynamic programming in parallel boundary detection with application to ultrasound intima-media segmentation

  2013cites this paper